Stroke, Vol 18, 911-918, Copyright © 1987 by American Heart Association
L Persson, HG Hardemark, J Gustafsson, G Rundstrom, I Mendel-Hartvig, T Esscher and S Pahlman
The development of a radioimmunoassay for S-100 protein is described. This
method was used in combination with a recently developed radioimmunoassay
for neuron-specific enolase in cerebrospinal fluid and serum from 47
patients with cerebral infarction, transient ischemic attack, intracerebral
hemorrhage, subarachnoid hemorrhage, and head injury. In cerebrospinal
fluid, increased concentrations of both S-100 and neuron-specific enolase
were found after large infarcts, whereas after small infarcts and transient
ischemic attacks, only neuron- specific enolase increased. The increased
concentrations of S-100 and/or neuron-specific enolase were noted 18 hours
to 4 days after cerebral infarction and transient ischemic attacks.
Cerebrospinal fluid concentrations of these proteins also reflected the
severity of the disease in patients with intracerebral hematoma,
subarachnoid hemorrhage, or head injury. Temporal changes in serum S-100
and neuron- specific enolase concentrations reflected the clinical course
in 4 patients. In stroke patients, the S-100 and neuron-specific enolase
concentrations may reflect the extent of brain damage and could be useful
in selecting patients with major stroke for more aggressive treatment
during the acute phase.
ARTICLES
S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system
This article has been cited by other articles:
![]() |
M Olivecrona, M Rodling-Wahlstrom, S Naredi, and L-O D Koskinen S-100B and neuron specific enolase are poor outcome predictors in severe traumatic brain injury treated by an intracranial pressure targeted therapy J. Neurol. Neurosurg. Psychiatry, November 1, 2009; 80(11): 1241 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. F. Laterza, L. Lim, P. W. Garrett-Engele, K. Vlasakova, N. Muniappa, W. K. Tanaka, J. M. Johnson, J. F. Sina, T. L. Fare, F. D. Sistare, et al. Plasma MicroRNAs as Sensitive and Specific Biomarkers of Tissue Injury Clin. Chem., November 1, 2009; 55(11): 1977 - 1983. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Hammon Extracorporeal Circulation: Organ Damage Card. Surg. Adult, January 1, 2008; 3(2008): 389 - 414. [Full Text] |
||||
![]() |
O. F. Laterza, V. R. Modur, D. L. Crimmins, J. V. Olander, Y. Landt, J.-M. Lee, and J. H. Ladenson Identification of Novel Brain Biomarkers Clin. Chem., September 1, 2006; 52(9): 1713 - 1721. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Petzold, G Keir, A Kay, M Kerr, and E J Thompson Axonal damage and outcome in subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry, June 1, 2006; 77(6): 753 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Allard, P. R. Burkhard, P. Lescuyer, J. A. Burgess, N. Walter, D. F. Hochstrasser, and J.-C. Sanchez PARK7 and Nucleoside Diphosphate Kinase A as Plasma Markers for the Early Diagnosis of Stroke Clin. Chem., November 1, 2005; 51(11): 2043 - 2051. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Springborg, H.-J. Frederiksen, V. Eskesen, and N. V. Olsen Trends in monitoring patients with aneurysmal subarachnoid haemorrhage Br. J. Anaesth., March 1, 2005; 94(3): 259 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Kofke, P. Konitzer, Q. C. Meng, J. Guo, and A. Cheung The Effect of Apolipoprotein E Genotype on Neuron Specific Enolase and S-100{beta} Levels After Cardiac Surgery Anesth. Analg., November 1, 2004; 99(5): 1323 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Plachky, S. Hofer, M. Volkmann, E. Martin, H. J. Bardenheuer, and M. A. Weigand Regional Cerebral Oxygen Saturation Is a Sensitive Marker of Cerebral Hypoperfusion During Orthotopic Liver Transplantation Anesth. Analg., August 1, 2004; 99(2): 344 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Vos, K. J.B. Lamers, J. C.M. Hendriks, M. van Haaren, T. Beems, C. Zimmerman, W. van Geel, H. de Reus, J. Biert, and M. M. Verbeek Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury Neurology, April 27, 2004; 62(8): 1303 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Motallebzadeh, R. Kanagasabay, M. Bland, J. C. Kaski, and M. Jahangiri S100 protein and its relation to cerebral microemboli in on-pump and off-pump coronary artery bypass surgery Eur. J. Cardiothorac. Surg., March 1, 2004; 25(3): 409 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Zimmermann-Ivol, P. R. Burkhard, J. Le Floch-Rohr, L. Allard, D. F. Hochstrasser, and J.-C. Sanchez Fatty Acid Binding Protein as a Serum Marker for the Early Diagnosis of Stroke: A Pilot Study Mol. Cell. Proteomics, January 1, 2004; 3(1): 66 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gazzolo, E. Marinoni, R. Di Iorio, M. Bruschettini, M. Kornacka, M. Lituania, U. Majewska, G. Serra, and F. Michetti Measurement of Urinary S100B Protein Concentrations for the Early Identification of Brain Damage in Asphyxiated Full-term Infants Arch Pediatr Adolesc Med, December 1, 2003; 157(12): 1163 - 1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ueno, Y. Iguro, H. Yamamoto, R. Sakata, Y. Kakihana, and K. Nakamura Serial measurement of serum S-100B protein as a marker of cerebral damage after cardiac surgery Ann. Thorac. Surg., June 1, 2003; 75(6): 1892 - 1897. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kay, A. Petzold, M. Kerr, G. Keir, E. Thompson, and J. Nicoll Decreased Cerebrospinal Fluid Apolipoprotein E After Subarachnoid Hemorrhage: Correlation With Injury Severity and Clinical Outcome Stroke, March 1, 2003; 34(3): 637 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mazzone, J. Gianetti, E. Picano, S. Bevilacqua, G. Zucchelli, A. Biagini, and M. Glauber Correlation between inflammatory response and markers of neuronal damage in coronary revascularization with and without cardiopulmonary bypass Perfusion, January 1, 2003; 18(1): 3 - 8. [Abstract] [PDF] |
||||
![]() |
S.-H. Oh, J.-G. Lee, S.-J. Na, J.-H. Park, Y.-C. Choi, and W.-J. Kim Prediction of Early Clinical Severity and Extent of Neuronal Damage in Anterior-Circulation Infarction Using the Initial Serum Neuron-Specific Enolase Level Arch Neurol, January 1, 2003; 60(1): 37 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Hammon Jr. and L. H. Edmunds Jr. Extracorporeal Circulation: Organ Damage Card. Surg. Adult, January 1, 2003; 2(2003): 361 - 388. [Full Text] |
||||
![]() |
J W Wirds, A E J Duyn, S D Geraerts, E Preijer, J A A M van Diemen-Steenvoorde, J H S. van Leeuwen, F J L M Haas, W B M Gerritsen, A de Boer, and J A Leusink S100 protein content of umbilical cord blood in healthy newborns in relation to mode of delivery Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2003; 88(1): F67 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
J R de Kruijk, P Leffers, P P C A Menheere, S Meerhoff, J Rutten, and A Twijnstra Prediction of post-traumatic complaints after mild traumatic brain injury: early symptoms and biochemical markers J. Neurol. Neurosurg. Psychiatry, December 1, 2002; 73(6): 727 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Slemmer, E. J. T. Matser, C. I. De Zeeuw, and J. T. Weber Repeated mild injury causes cumulative damage to hippocampal cells Brain, December 1, 2002; 125(12): 2699 - 2709. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Michetti and D. Gazzolo S100B Protein in Biological Fluids: A Tool for Perinatal Medicine Clin. Chem., December 1, 2002; 48(12): 2097 - 2104. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Elting, G. A. Sulter, M. Kaste, K. R. Lees, H. C. Diener, M. Hommel, M. Versavel, A. W. Teelken, and J. De Keyser AMPA Antagonist ZK200775 in Patients With Acute Ischemic Stroke: Possible Glial Cell Toxicity Detected by Monitoring of S-100B Serum Levels Stroke, December 1, 2002; 33(12): 2813 - 2818. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ozatik, O. Tarcan, A. Kale, G. Askon, M. Balco, A. Undar, D. S. Kucukaksu, E. Sener, and O. Tasdemir Do S100{beta} protein level increases due to inflammation during cardiopulmonary bypass occur without any neurological deficit? Perfusion, September 1, 2002; 17(5): 335 - 338. [Abstract] [PDF] |
||||
![]() |
W. Jordan, J. Hagedohm, J. Wiltfang, G. Laier-Groeneveld, H. Tumani, A. Rodenbeck, E. Ruther, and G. Hajak Biochemical markers of cerebrovascular injury in sleep apnoea syndrome Eur. Respir. J., July 1, 2002; 20(1): 158 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tokuno, K. Hinokiyama, K. Tokuno, C. Lowbeer, L.-O. Hansson, and G. Valen Spontaneous Ischemic Events in the Brain and Heart Adapt the Hearts of Severely Atherosclerotic Mice to Ischemia Arterioscler Thromb Vasc Biol, June 1, 2002; 22(6): 995 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wong, K. Ess, and M. Landt Cerebrospinal Fluid Neuron-Specific Enolase Following Seizures in Children: Role of Etiology J Child Neurol, April 1, 2002; 17(4): 261 - 264. [Abstract] [PDF] |
||||
![]() |
D. Gazzolo, M. Bruschettini, R. Di Iorio, E. Marinoni, M. Lituania, M. Marras, R. Sarli, P. L. Bruschettini, and F. Michetti Maternal Nitric Oxide Supplementation Decreases Cord Blood S100B in Intrauterine Growth-retarded Fetuses Clin. Chem., April 1, 2002; 48(4): 647 - 650. [Full Text] [PDF] |
||||
![]() |
B. Krishnadasan, C. R. Hampton, J. Griscavage-Ennis, R. J. Dabal, and E. D. Verrier Molecular Mechanisms of Neurologic Injury Following Cardiopulmonary Bypass Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2002; 6(1): 43 - 53. [Abstract] [PDF] |
||||
![]() |
J de Vries, W A M H Thijssen, S E A Snels, T Menovsky, N G M Peer, and K J B Lamers Intraoperative values of S-100 protein, myelin basic protein, lactate, and albumin in the CSF and serum of neurosurgical patients J. Neurol. Neurosurg. Psychiatry, November 1, 2001; 71(5): 671 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. A. Robson, R. P. Alston, I. J. Deary, P. J. D. Andrews, and M. J. Souter Jugular Bulb Oxyhemoglobin Desaturation, S100{beta}, and Neurologic and Cognitive Outcomes After Coronary Artery Surgery Anesth. Analg., October 1, 2001; 93(4): 839 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
M W Agelink, J Andrich, T Postert, U Wurzinger, T Zeit, P Klotz, and H Przuntek Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100 J. Neurol. Neurosurg. Psychiatry, September 1, 2001; 71(3): 394 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rodriguez-Nunez, E. Cid, J. Rodriguez-Garcia, F. Camifia, S. Rodriguez-Segade, and M. Castro-Gago Concentrations of Nucleotides, Nucleosides, Purine Bases, Oxypurines, Uric Acid, and Neuron-Specific Enolase in the Cerebrospinal Fluid of Children With Sepsis J Child Neurol, September 1, 2001; 16(9): 704 - 706. [Abstract] [PDF] |
||||
![]() |
A J E Green, E J Thompson, G E Stewart, M Zeidler, J M McKenzie, M-A MacLeod, J W Ironside, R G Will, and R S G Knight Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease J. Neurol. Neurosurg. Psychiatry, June 1, 2001; 70(6): 744 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Anderson, L.-O. Hansson, O. Nilsson, J. Liska, G. Settergren, and J. Vaage Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources Ann. Thorac. Surg., May 1, 2001; 71(5): 1512 - 1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Whitelaw, L Rosengren, and M Blennow Brain specific proteins in posthaemorrhagic ventricular dilatation Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2001; 84(2): 90F - 91. [Abstract] [Full Text] |
||||
![]() |
D. N. Derkach, H. Okamoto, and S. Takahashi Neuronal and Astroglial Injuries in Patients Undergoing Coronary Artery Bypass Grafting and Aortic Arch Replacement During Hypothermic Cardiopulmonary Bypass Anesth. Analg., November 1, 2000; 91(5): 1066 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Ali, M. Harmer, and R. Vaughan Serum S100 protein as a marker of cerebral damage during cardiac surgery Br. J. Anaesth., August 1, 2000; 85(2): 287 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Missler, M. Wiesmann, P. Ehlermann, M. Tronnier, A. Notzold, E. Steinmeier, and W. G. Wood Validation and Comparison of Two Solid-Phase Immunoassays for the Quantification of S-100B in Human Blood Clin. Chem., July 1, 2000; 46(7): 993 - 996. [Full Text] [PDF] |
||||
![]() |
P. Johnsson, S. Blomquist, C. Luhrs, G. Malmkvist, C. Alling, J.-O. Solem, and E. Stahl Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation Ann. Thorac. Surg., March 1, 2000; 69(3): 750 - 754. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Anderson, L.-O. Hansson, J. Liska, G. Settergren, and J. Vaage The effect of cardiotomy suction on the brain injury marker S100{beta} after cardiopulmonary bypass Ann. Thorac. Surg., March 1, 2000; 69(3): 847 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Hammon Jr and D. Stump COMMENTARY: BIOCHEMICAL MARKERS OF BRAIN INJURY AFTER CARDIAC SURGERY J. Thorac. Cardiovasc. Surg., January 1, 2000; 119(1): 130 - 131. [Full Text] [PDF] |
||||
![]() |
H. Jonsson, P. Johnsson, C. Alling, M. Backstrom, C. Bergh, and S. Blomquist S100{beta} after coronary artery surgery: release pattern, source of contamination, and relation to neuropsychological outcome Ann. Thorac. Surg., December 1, 1999; 68(6): 2202 - 2208. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bhattacharya, S. Westaby, R. Pillai, S. J. Standing, P. Johnsson, and D. P. Taggart Serum S100B and hypothermic circulatory arrest in adults Ann. Thorac. Surg., October 1, 1999; 68(4): 1225 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kilminster, T. Treasure, T. McMillan, and D. W. Holt Neuropsychological Change and S-100 Protein Release in 130 Unselected Patients Undergoing Cardiac Surgery Stroke, September 1, 1999; 30(9): 1869 - 1874. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wimmer-Greinecker, G. Matheis, S. Martens, G. Oremek, U. Abdel-Rahman, and A. Moritz Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences Eur. J. Cardiothorac. Surg., August 1, 1999; 16(2): 211 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takahashi, A. Chamczuk, Y. Hong, and G. Jackowski Rapid and Sensitive Immunoassay for the Measurement of Serum S100B Using Isoform-specific Monoclonal Antibody Clin. Chem., August 1, 1999; 45(8): 1307 - 1311. [Full Text] [PDF] |
||||
![]() |
W. Schoerkhuber, H. Kittler, F. Sterz, W. Behringer, M. Holzer, M. Frossard, S. Spitzauer, and A. N. Laggner Time Course of Serum Neuron-Specific Enolase : A Predictor of Neurological Outcome in Patients Resuscitated From Cardiac Arrest Stroke, August 1, 1999; 30(8): 1598 - 1603. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Anderson, L.-O. Hansson, and J. Vaage Release of S100B during coronary artery bypass grafting is reduced by off-pump surgery Ann. Thorac. Surg., June 1, 1999; 67(6): 1721 - 1725. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Raabe, D. K Menon, S. Gupta, M. Czosnyka, and J. D Pickard Jugular venous and arterial concentrations of serum S-100B protein in patients with severe head injury: a pilot study J. Neurol. Neurosurg. Psychiatry, December 1, 1998; 65(6): 930 - 932. [Abstract] [Full Text] |
||||
![]() |
H. Jonsson, P. Johnsson, C. Alling, S. Westaby, and S. Blomquist Significance of Serum S100 Release After Coronary Artery Bypass Grafting Ann. Thorac. Surg., June 1, 1998; 65(6): 1639 - 1644. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Grocott, N. D. Croughwell, D. W. Amory, W. D. White, J. L. Kirchner, and M. F. Newman Cerebral Emboli and Serum S100{beta} During Cardiac Operations Ann. Thorac. Surg., June 1, 1998; 65(6): 1645 - 1649. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gazzolo, P. Vinesi, M. C. Geloso, C. Marcelletti, F. S. Iorio, A. Cipriani, S. M. Marianeschi, and F. Michetti S100 Blood Concentrations in Children Subjected to Cardiopulmonary By-Pass Clin. Chem., May 1, 1998; 44(5): 1058 - 1060. [Full Text] [PDF] |
||||
![]() |
M. Otto, J. Wiltfang, E. Schütz, I. Zerr, A. Otto, A. Pfahlberg, O. Gefeller, M. Uhr, A. Giese, T. Weber, et al. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study BMJ, February 14, 1998; 316(7131): 577 - 582. [Abstract] [Full Text] |
||||
![]() |
A. Martin-Ancel, A. Garcia-Alix, D. Pascual-Salcedo, F. Cabanas, M. Valcarce, and J. Quero Interleukin-6 in the Cerebrospinal Fluid After Perinatal Asphyxia Is Related to Early and Late Neurological Manifestations Pediatrics, November 1, 1997; 100(5): 789 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J H Jongen, K. J B Lamers, W. H Doesburg, W. A J G Lemmens, and O. R Hommes Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis J. Neurol. Neurosurg. Psychiatry, October 1, 1997; 63(4): 446 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Missler, M. Wiesmann, C. Friedrich, and M. Kaps S-100 Protein and Neuron-Specific Enolase Concentrations in Blood as Indicators of Infarction Volume and Prognosis in Acute Ischemic Stroke Stroke, October 1, 1997; 28(10): 1956 - 1960. [Abstract] [Full Text] |
||||
![]() |
T. Buttner, S. Weyers, T. Postert, R. Sprengelmeyer, and W. Kuhn S-100 Protein: Serum Marker of Focal Brain Damage After Ischemic Territorial MCA Infarction Stroke, October 1, 1997; 28(10): 1961 - 1965. [Abstract] [Full Text] |
||||
![]() |
O. Nygaard, B. Langbakk, and B. Romner Age- and Sex-Related Changes of S-100 Protein Concentrations in Cerebrospinal Fluid and Serum in Patients with No Previous History of Neurological Disorder Clin. Chem., March 1, 1997; 43(3): 541 - 543. [Full Text] |
||||
![]() |
D. P. Taggart, J. W. Mazel, K. Bhattacharya, N. Meston, S. J. Standing, J. D. S. Kay, R. Pillai, P. Johnssson, and S. Westaby Comparison of Serum S-100{beta} Levels During CABG and Intracardiac Operations Ann. Thorac. Surg., February 1, 1997; 63(2): 492 - 496. [Abstract] [Full Text] |
||||
![]() |
R.J. Butterworth, W.S. Wassif, R.A. Sherwood, A. Gerges, K.H. Poyser, J. Garthwaite, T.J. Peters, and P.M.W. Bath Serum Neuron-Specific Enolase, Carnosinase, and Their Ratio in Acute Stroke: An Enzymatic Test for Predicting Outcome? Stroke, November 1, 1996; 27(11): 2064 - 2068. [Abstract] [Full Text] |
||||
![]() |
J. S. Kim, S. S. Yoon, Y. H. Kim, and J. S. Ryu Serial Measurement of Interleukin-6, Transforming Growth Factor-ß, and S-100 Protein in Patients With Acute Stroke Stroke, September 1, 1996; 27(9): 1553 - 1557. [Abstract] [Full Text] |
||||
![]() |
S. Westaby, P. Johnsson, A. J. Parry, S. Blomqvist, J.-O. Solem, C. Alling, R. Pillai, D. P. Taggart, C. Grebenik, and E. Stahl Serum S100 Protein: A Potential Marker for Cerebral Events During Cardiopulmonary Bypass Ann. Thorac. Surg., January 1, 1996; 61(1): 88 - 92. [Abstract] [Full Text] |
||||
![]() |
M. Horn, F. Seger, and W. Schlote Neuron-Specific Enolase in Gerbil Brain and Serum After Transient Cerebral Ischemia Stroke, February 1, 1995; 26(2): 290 - 297. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |